(Q53307564)

English

Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.

scientific article published in November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12404282%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12404282%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

based on heuristic

inferred from title

Paweł Sedlaczek

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12404282%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12404282%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

2

object named as

Irena Frydecka

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12404282%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

Arie Van Dalen

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12404282%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Roland Einarsson

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12404282%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Antonina Harłozińska

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12404282%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

language of work or name

0 references

publication date

1 November 2002

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12404282%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12404282%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

95

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12404282%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1886-1893

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12404282%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12404282%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

The CA 125 tumour-associated antigen: a review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Transmembrane signalling by interleukin 2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

The soluble interleukin-2 receptor: biology, function, and clinical application

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Soluble interleukin 2 receptor (sIL2R) in monitoring advanced lung cancer during chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

The biological significance of soluble interleukin-2 receptors in solid tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

CA 125 kinetics: a cost-effective clinical tool to evaluate clinical trial outcomes in the 1990s

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

The prognostic value of pretherapeutic tetranectin and CA-125 in patients with relapse of ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Tumour associated antigens in diagnosis of serous effusions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

How CA 125 is used in routine clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Preoperative prediction of optimal resectability in advanced ovarian cancer using CA-125

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma: a multicenter study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Predictive value of the combination of serum markers, CA125, CASA and TPS in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Tissue polypeptide-specific antigen and CA 125 as serum tumor markers in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Levels of soluble interleukin-2 receptor-α are elevated in serum and ascitic fluid from epithelial ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Serum and cystic fluid levels of soluble interleukin-2 receptor-alpha in patients with epithelial ovarian tumors are correlated

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Clinical value of tumour markers and serum-ascites albumin gradient in the diagnosis of malignancy-related ascites

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10917

21 January 2018

Identifiers

10.1002/CNCR.10917

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12404282%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12404282%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53307564&oldid=2099739369"